KRISTEN GROVE: Open Payments
NPI 1093238123 · CARY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$630 in 34 payments from 13 companies in 2025. Trend: 2023 $1,991 · 2024 $2,240 · 2025 $630
Food & beverage: $630
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $112 |
| Otsuka America Pharmaceutical, Inc. | 6 | $110 |
| Lundbeck LLC | 4 | $68 |
| ABBVIE INC. | 4 | $65 |
| Axsome Therapeutics, Inc. | 3 | $50 |
| Neurocrine BioSciences, Inc. | 2 | $41 |
| Vanda Pharmaceuticals Inc. | 2 | $40 |
| Janssen Pharmaceuticals, Inc | 2 | $32 |
| Lilly USA, LLC | 2 | $31 |
| Supernus Pharmaceuticals, Inc. | 2 | $29 |
Products named: REXULTI, CAPLYTA, INGREZZA, Auvelity, VRAYLAR, QULIPTA, SPRAVATO, AMYVID.
Industry payments across NC — which companies pay providers there.
